Anlotinib Drives Hepatoblastoma Resistance via GAD1/GABA
Intrinsic drug resistance remains one of the formidable challenges in cancer therapy, often thwarting the efficacy of promising treatments and ...
Intrinsic drug resistance remains one of the formidable challenges in cancer therapy, often thwarting the efficacy of promising treatments and ...
In a groundbreaking study poised to reshape therapeutic strategies for hepatocellular carcinoma (HCC), researchers have demonstrated the superior efficacy and ...
Ewing’s sarcoma (ES) stands as one of the most aggressive primary bone malignancies, predominantly afflicting children and adolescents. This rare ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine